View the MYOPAS TABLET registration information details.
Back to drug list
ItemsDrug Registration information
ID1232
No1232
Brand NameMYOPAS TABLET
IngredientsPARACETAMOL 450 MG, ORPHENADRINE CITRATE 35 MG
Dosage FormTABLET
Primary PackagingALU-ALU STRIP
Storage
Shelf Life4 YEARS
Pack SizeBOX OF 10 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE TREATMENT OF MILD TO MODERATE PAIN INCLUDING HEADACHE, MIGRAINE, NEURALGIA, TOOTHACHE, SORE THROAT, PERIOD PAINS, ACHES AND PAINS, SYMPTOMATIC RELIEF OF RHEUMATIC ACHES AND PAINS AND OF INFLUENZA, FEVERISHNESS AND FEVERISH COLDS.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionA WHITE, PILLOW SHAPE, FLAT TABLET WITH A BREAK - LINE ON ONE SIDE
Note
License OwnerKONGCHAI-LAO PHARMA SOLE CO.,LTD
ManufacturerT.MAN PHARMA CO.,LTD
CountryTHAILAND
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No05 I 4265/17
FDD Registration Date09/07/2024
Expiry Date08/07/2027
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA